Author:
Moderegger Eva Lotta,Schmitz Marie J.,Ludwig Ralf J.,Sadik Christian D.,Schmidt Enno
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Amagai M, Ikeda S, Hashimoto T et al (2017) A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid. J Dermatol Sci 85:77–84
2. Bertram F, Brocker EB, Zillikens D et al (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 7:434–440
3. Bieber K, Koga H, Nishie W (2017) In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases. Exp Dermatol 26:1163–1170
4. Borradori L, Van Beek N, Feliciani C et al (2022) Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 36:1689–1704
5. Dainichi T, Kurono S, Ohyama B et al (2009) Anti-laminin gamma‑1 pemphigoid. Proc Natl Acad Sci U S A 106:2800–2805
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献